Cargando…

A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapy

Castleman's disease (CD) is an uncommon lymphoproliferative process that can present concurrent to other solid organ malignancy, especially in selected populations. Concomitant CD and renal cell carcinoma (RCC) are challenging in terms of diagnosis and treatment. Assessment of CD involvement is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lozar, Taja, Brunner, Matthew J., Shah, Sujal I., Kyriakopoulos, Christos E., Emamekhoo, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163955/ https://www.ncbi.nlm.nih.gov/pubmed/34094876 http://dx.doi.org/10.1016/j.eucr.2021.101720

Ejemplares similares

PARP inhibitors in metastatic prostate cancer
por: Taylor, Amy K., et al.
Publicado: (2023)

Understanding the Tumor Immune Microenvironment in Renal Cell Carcinoma
por: Shapiro, Daniel D., et al.
Publicado: (2023)

Concomitant perinephric Castleman disease and renal cell carcinoma initially suspected to be metastasis: A case report and 24 months follow up
por: Dong, Yi, et al.
Publicado: (2018)

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports
por: Tucker, Matthew D., et al.
Publicado: (2020)

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort
por: Barata, Pedro, et al.
Publicado: (2020)

Castleman disease in the scrotum
por: Song, Zhen, et al.
Publicado: (2021)

Retroperitoneal castleman disease mimicking lymph node spread from clear renal cell carcinoma. A case report
por: de Campos, Eurico Cleto Ribeiro, et al.
Publicado: (2020)

Urinary Bladder Paraganglioma and Concomitant Metastatic Lung Cancer. A Case Report
por: Gkikas, Christos, et al.
Publicado: (2016)

Preclinical and Clinical Evaluation of Magnetic-Activated Cell Separation Technology for CTC Isolation in Breast Cancer
por: Lozar, Taja, et al.
Publicado: (2020)

Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
por: Raimondi, Alessandra, et al.
Publicado: (2020)

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
por: Gu, Cheng-Yuan, et al.
Publicado: (2021)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Surgical challenges of Castleman's disease of the pelvis
por: Nepal, Sat Prasad, et al.
Publicado: (2020)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era
por: Scheipner, Lukas, et al.
Publicado: (2023)

Castleman Disease Presenting as Renal Hilar Mass
por: Radfar, Mohammad Hadi, et al.
Publicado: (2015)

The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade
por: Olsen, T. Anders, et al.
Publicado: (2021)

Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab
por: Bloom, Brooke C., et al.
Publicado: (2019)

Immune-related lichenoid mucocutaneous erosions during anti-PD-1 immunotherapy in metastatic renal cell carcinoma - A case report
por: Lindner, Andrea Katharina, et al.
Publicado: (2018)

A Rare Case of Renal Cell Carcinoma With Leiomyomatous Stroma and Concomitant Ruptured Adrenal Aneurysm
por: Lu, Chuanyong, et al.
Publicado: (2016)

Recurrent papillary renal cell carcinoma with concomitant ipsilateral upper urinary tract urothelial carcinoma and metachronous urothelial carcinoma of the bladder
por: Banapour, Pooya, et al.
Publicado: (2018)

Abscopal effect in metastatic breast cancer treated with stereotactic body radiotherapy in the absence of immunotherapy
por: Kim, Jae Sik, et al.
Publicado: (2023)

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
por: Mohammad, H., et al.
Publicado: (2021)

Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?
por: Shah, Amishi Y., et al.
Publicado: (2015)

The role of immunotherapy in non-clear cell renal cell carcinoma
por: Climent, Carla, et al.
Publicado: (2023)

Immuno-oncology therapy associated thromboembolic events in metastatic renal cell carcinoma
por: Alhamdani, Zein, et al.
Publicado: (2023)

Targeted therapies for previously treated advanced or metastatic renal cell carcinoma: systematic review and network meta-analysis
por: Karner, Charlotta, et al.
Publicado: (2019)

Plasma cell variant of Castleman lymphadenopathy presenting as an adrenal mass
por: Mindiola-Romero, Andres E., et al.
Publicado: (2021)

Castleman disease mimicking an adrenal tumor: A case report
por: Maghsoudi, Robab, et al.
Publicado: (2021)

Unicentric form of Castleman´s disease, pitfalls of diagnosis and surgical treatment
por: Molacek, Jiri, et al.
Publicado: (2023)

Metastatic renal cell carcinoma to the prostate and seminal vesicle
por: Wiesen, Brett, et al.
Publicado: (2020)

Metastatic renal cell carcinoma in the bladder following complex partial nephrectomy: A case report
por: Boynton, Dennis N., et al.
Publicado: (2022)

Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma
por: Tucker, Matthew D., et al.
Publicado: (2020)

Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience
por: Bimbatti, Davide, et al.
Publicado: (2022)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Perspectives on Immunotherapy of Metastatic Colorectal Cancer
por: Dai, Yongjiu, et al.
Publicado: (2021)

Classical Hodgkin Lymphoma on the Background of Castleman Disease: A Case Report
por: Ma'koseh, Mohammad, et al.
Publicado: (2023)

Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi
por: Painschab, Matthew S., et al.
Publicado: (2022)

Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
por: McNeel, Douglas G, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lsj303mto3oaiuh4raca5q8s84